Company intelligence / Profile preview

Global BioAccess Fund

New York, New York, United Statesglobalbioaccess.com ↗

Ownership: Private
Development stage: Other

Overview

Global BioAccess Fund is an active venture capital/investment banking firm focused on early-stage life science and medical technology companies. It provides funding to support novel therapeutics and devices addressing serious unmet needs across multiple therapeutic areas. The fund has participated in several notable financings including Series B rounds for innovative biotech firms such as Acesion Pharma (atrial fibrillation therapies) and Nuvig Therapeutics.

Therapeutic areas: OncologyCardiovascularRare DiseasesNeurology
Modalities: Small moleculeBiologicDevice
Industry: Investors

Partnerships

KB Investment Co.RM Global Partners LLCCanaanAlpha Wave

Beyond the preview

Go deeper on Global BioAccess Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Global BioAccess Fund.

Explore the full profile